Back to Search Start Over

Novavax expands collaboration and license agreement with SK bioscience, Co. Limited for NVX-CoV2373

Source :
M2 Pharma. December 24, 2021
Publication Year :
2021

Abstract

M2 PHARMA-December 24, 2021-Novavax expands collaboration and license agreement with SK bioscience, Co. Limited for NVX-CoV2373 (C)2021 M2 COMMUNICATIONS Novavax, Inc. (Nasdaq: NVAX), a biotechnology company, announced on Thursday that [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
M2 Pharma
Publication Type :
News
Accession number :
edsgcl.687793574